Press Release Archive


  2023 / 2022 / 2021 / 2020 / 2019 / 2018 / 2017 / 2016 / 2015 / 2014 / 2013

Thursday, December 10, 2015

New Primary Ciliary Dyskinesia Center at UH Rainbow Babies & Children’s Hospital first in U.S. fully accredited by PCD Foundation

CLEVELAND – University Hospitals Rainbow Babies & Children’s Hospital’s (UH Rainbow) new Primary Ciliary Dyskinesia Center is the first in the U.S. to be site-visited and fully accredited by the Primary Ciliary Dyskinesia (PCD) Foundation. It is estimated as many as 20,000 Americans have PCD but fewer than 1,000 have received a definitive diagnosis.

PCD is a genetic disorder of the function of cilia—tiny, microscopic moving structures that line the airways, ears and sinuses. The sweeping, wave-like motion of cilia is important for keeping these areas clean and free from infection. Without properly functioning cilia, people with PCD are unable to protect their respiratory system. Frequent infections of the lungs, ears and sinuses are common and can lead to serious and permanent damage.

“Proper diagnosis of PCD remains a challenge,” says Benjamin Gaston, MD, Chief, Pediatric Pulmonology and Director of the new PCD Center at UH Rainbow. “About 70 percent of PCD patients have a positive genetic test, and that number is getting higher every year. But to make a valid diagnosis requires considering several different factors and tests that can easily be misinterpreted.”

Thursday, December 10, 2015

University Hospitals selected as health care partner and provider for the Mid-American Conference

CLEVELAND – The Mid-American Conference (MAC) has entered into an agreement and formally announced today the partnership with University Hospitals (UH) as the official health care provider of the MAC.
As the official health care partner of the MAC, University Hospitals Case Medical Center, the health system’s nationally recognized academic medical center, will provide a complete multi-disciplinary team of physician specialists covering the MAC’s championship health care needs.
This three-year agreement stipulates that UH will provide medical counsel and coverage for students at all of the 23 sponsored MAC tournament championship games. In total, the agreement will provide over 5,000 students with medical care under UH. The innovative collaboration was brokered by IMG, the MAC’s multi-media rights partner.

Tuesday, December 08, 2015

Neurosurgery researchers receive NIH grants to study Parkinson’s, stroke and brain cancer

CLEVELAND – Researchers from the Department of Neurological Surgery at Case Western Reserve University School of Medicine and University Hospitals Case Medical Center recently received multi-year, multi-million dollar grants from the National Institutes of Health (NIH) for studies in Parkinson’s disease, stroke, and brain cancer.
Barry J. Hoffer, MD, PhD, adjunct professor of neurosurgery at Case Western Reserve and a member of the Department of Neurosurgery at UH Case Medical Center, received a 3-year,
$1 million grant for continuing research into gliptins for the treatment of Parkinson’s disease.  Gliptins, widely used in the effective treatment of type 2 diabetes to safely regulate blood glucose levels, also have been found to provide neurological protection in Parkinson’s.  In rat studies, gliptins increase levels of hormones called incretins which reduced Parkinson’s symptoms.
The new grant will enable Dr. Hoffer and colleagues to continue their evaluation of gliptins as a new treatment strategy for Parkinson’s in mouse models.

Tuesday, December 08, 2015

New technology developed at University Hospitals Case Medical Center may standardize Sickle Cell Disease screenings for infants in developing countries

CLEVELAND – Researchers from Seidman Cancer Center at University Hospitals Case Medical Center and Case Western Reserve University School of Medicine presented new research findings this weekend at the 57th Annual Meeting of the American Society of Hematology (ASH) in Orlando.  
In a poster presentation (Abstract #3379), Yunus Alapan, Umut Gurkan PhD and Jane Little, MD presented promising findings related to new technology aimed at facilitating early detection of sickle cell disease for infants in developing countries. Current standardized screening methods are too costly and take too much time to enable equitable and timely diagnosis to save lives in economically challenged nations. However, an innovative mobile biochip device, the HemeChip, has the unique ability to rapidly screen for sickle cell disease with just a few drops of blood.
“While sickle cell newborn screening is standard in the U.S., very few infants are screened in Africa because of the high cost and level of skill needed to run traditional tests,” says Dr. Little, Director of the Adult Sickle Cell Anemia Center, UH Seidman Cancer Center and Associate Professor at the School of Medicine. “This new mobile technology provides an easy to use, cost-effective tool that takes us closer to standardizing newborn screenings on mobile devices, thus simplifying diagnosis. It could make a huge difference in developing nations worldwide, enabling early treatment for this disease.”

University Hospitals Case Medical Center names Daniel I. Simon, MD, as new President
Friday, December 04, 2015

University Hospitals Case Medical Center names Daniel I. Simon, MD, as new President

CLEVELAND – University Hospitals Case Medical Center has appointed Daniel I. Simon, MD, as the academic medical center’s new President effective Jan. 1, 2016.

Dr. Simon will succeed Fred C. Rothstein, MD, who announced his retirement this summer after serving as President of UH Case Medical Center and one of the most influential leaders at the health system for the past 12 years.

Dr. Simon is a nationally renowned leader in the field of cardiology. His dynamic leadership qualities and collegial style have enhanced the prominence of UH Harrington Heart & Vascular Institute, where he has served as Director since 2006 and as President since 2014. Throughout his tenure, he and his team have developed and executed growth, business and clinical strategies to enhance patient access, clinical integration and quality outcomes. Additionally, he has served as Chief of the Division of Cardiovascular Medicine at UH Case Medical Center and Professor of Medicine at Case Western Reserve University School of Medicine. He also holds the Herman K. Hellerstein, MD, Chair in Cardiovascular Research at UH Case Medical Center and the School of Medicine. 

  • News Media Access

  • Register
  • Forgot My Password
  • Search:

    Advanced Search

  • Subscribe To Our Latest News

    Subscribe to University Hospitals' RSS Feeds or Email Alerts to get our latest news.

    University Hospitals RSS Feed  University Hospitals Email Alerts
  • Twitter

    Must select a Twitter Account for Rail Gadget in Twitter Tool.

You must be logged in to view this item.


This area is reserved for members of the news media. If you qualify, please update your user profile and check the box marked "Check here to register as an accredited member of the news media". Please include any notes in the "Supporting information for media credentials" box. We will notify you of your status via e-mail in one business day.